174 related articles for article (PubMed ID: 522521)
41. Influence of the sulphation inhibitor, 2,6-dichloro-4-nitrophenol, on the production and conjugation, of 4-hydroxybiphenyl generated from 4-methoxybiphenyl by rat isolated hepatocytes.
Fry JR; Paterson P
Biochem Pharmacol; 1987 Sep; 36(18):3090-2. PubMed ID: 3632729
[No Abstract] [Full Text] [Related]
42. Para-nitrophenol glucuronidation and sulfation in rat and human liver slices.
Kuhn UD; Rost M; Müller D
Exp Toxicol Pathol; 2001 Apr; 53(1):81-7. PubMed ID: 11370739
[TBL] [Abstract][Full Text] [Related]
43. The role of sulfation in the metabolic activation of N-hydroxy-4'-fluoro-4-acetylaminobiphenyl.
van de Poll ML; Tijdens RB; Vondrácek P; Bruins AP; Meijer DK; Meerman JH
Carcinogenesis; 1989 Dec; 10(12):2285-91. PubMed ID: 2480190
[TBL] [Abstract][Full Text] [Related]
44. Glycogenolysis--and not gluconeogenesis--is the source of UDP-glucuronic acid for glucuronidation.
Bánhegyi G; Garzó T; Antoni F; Mandl J
Biochim Biophys Acta; 1988 Dec; 967(3):429-35. PubMed ID: 3196758
[TBL] [Abstract][Full Text] [Related]
45. Sulfation and glucuronidation as competing pathways in the metabolism of hydroxamic acids: the role of N,O-sulfonation in chemical carcinogenesis of aromatic amines.
Mulder GJ; Meerman JH
Environ Health Perspect; 1983 Mar; 49():27-32. PubMed ID: 6339226
[TBL] [Abstract][Full Text] [Related]
46. Effect of inducers and inhibitors of glucuronidation on the biliary excretion and choleretic action of valproic acid in the rat.
Watkins JB; Klaassen CD
J Pharmacol Exp Ther; 1982 Feb; 220(2):305-10. PubMed ID: 6799642
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of sulphation of phenolic substances by the carboxylesterase inhibitor bis-(p-nitrophenyl)-phosphate in the rat in vivo.
Koster H; Schlotens E; Mulder GJ
Biochem Pharmacol; 1979 Sep; 28(17):2685-6. PubMed ID: 518682
[No Abstract] [Full Text] [Related]
48. UDP glucuronyltransferase and phenolsulfotransferase from rat liver in vivo and in vitro. III. The effect of phenolphthalein and its sulfate and glucuronide conjugate on conjugation and biliary excretion of harmol.
Mulder GJ; Pilon AH
Biochem Pharmacol; 1975 Feb; 24(4):517-21. PubMed ID: 803377
[No Abstract] [Full Text] [Related]
49. Human intestinal phenol sulfotransferase: assay conditions, activity levels and partial purification of the thermolabile form.
Sundaram RS; Szumlanski C; Otterness D; van Loon JA; Weinshilboum RM
Drug Metab Dispos; 1989; 17(3):255-64. PubMed ID: 2568905
[TBL] [Abstract][Full Text] [Related]
50. Renal tubular conjugation and excretion of phenol and p-nitrophenol in the chicken: differing mechanisms of renal transfer.
Quebbemann AJ; Anders MW
J Pharmacol Exp Ther; 1973 Mar; 184(3):695-708. PubMed ID: 4687232
[No Abstract] [Full Text] [Related]
51. Depletion of hepatic 3'-phosphoadenosine 5'-phosphosulfate (PAPS) and sulfate in rats by xenobiotics that are sulfated.
Kim HJ; Cho JH; Klaassen CD
J Pharmacol Exp Ther; 1995 Nov; 275(2):654-8. PubMed ID: 7473151
[TBL] [Abstract][Full Text] [Related]
52. The availability of inorganic sulphate in blood for sulphate conjugation of drugs in rat liver in vivo. (35S)Sulphate incorporation into harmol sulphate.
Mulder GJ; Scholtens E
Biochem J; 1978 May; 172(2):247-51. PubMed ID: 666743
[TBL] [Abstract][Full Text] [Related]
53. D-cysteine as a selective precursor for inorganic sulfate in the rat in vivo. Effect of D-cysteine on the sulfation of harmol.
Glazenburg EJ; Jekel-Halsema IM; Baranczyk-Kuzma A; Krijgsheld KR; Mulder GJ
Biochem Pharmacol; 1984 Feb; 33(4):625-8. PubMed ID: 6704178
[TBL] [Abstract][Full Text] [Related]
54. The availability of inorganic sulphate as a rate limiting factor in the sulphate conjugation of xenobiotics in the rat? Sulphation and glucuronidation of phenol.
Weitering JG; Krijgsheld KR; Mulder GJ
Biochem Pharmacol; 1979 Mar; 28(6):757-62. PubMed ID: 454475
[No Abstract] [Full Text] [Related]
55. Effect of glutathione depletion on sulfate activation and sulfate ester formation in rats.
Gregus Z; White C; Howell S; Klaassen CD
Biochem Pharmacol; 1988 Nov; 37(22):4307-12. PubMed ID: 3196355
[TBL] [Abstract][Full Text] [Related]
56. Effects of model traumatic injury on hepatic drug metabolism in the rat. V. Sulfation and acetylation.
Griffeth LK; Rosen GM; Rauckman EJ
Drug Metab Dispos; 1985; 13(4):398-405. PubMed ID: 2863101
[TBL] [Abstract][Full Text] [Related]
57. Sequential metabolism of salicylamide exclusively to gentisamide 5-glucuronide and not gentisamide sulfate conjugates in single-pass in situ perfused rat liver.
Xu X; Tang BK; Pang KS
J Pharmacol Exp Ther; 1990 Jun; 253(3):965-73. PubMed ID: 2359032
[TBL] [Abstract][Full Text] [Related]
58. Effect of fatty acids on formation, distribution, storage, and release of benzo(a)pyrene phenols and glucuronides in the isolated perfused rat liver.
Zhong Z; Gao W; Kauffman FC; Thurman RG
Cancer Res; 1989 Apr; 49(8):2012-6. PubMed ID: 2702643
[TBL] [Abstract][Full Text] [Related]
59. Carrier-mediated entry of 4-methylumbelliferyl sulfate: characterization by the multiple-indicator dilution technique in perfused rat liver.
Chiba M; Schwab AJ; Goresky CA; Pang KS
Hepatology; 1998 Jan; 27(1):134-46. PubMed ID: 9425929
[TBL] [Abstract][Full Text] [Related]
60. Depletion of hepatic uridine diphosphoglucuronic acid decreases the biliary excretion of drugs.
Gregus Z; Watkins JB; Thompson TN; Klaassen CD
J Pharmacol Exp Ther; 1983 May; 225(2):256-62. PubMed ID: 6405026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
